Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Orgenesis Inc. ORGS
$1.09
+$0.01 (0.92%)
На 18:01, 12 мая 2023
Ранг: 1
Ключевые показатели
-
Marketcap
30161484.00000000
-
week52high
3.00
-
week52low
0.98
-
Revenue
36025000
-
P/E TTM
-2
-
Beta
0.92525900
-
EPS
-0.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
22 мая 2023 г. в 18:15
Описание компании
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Benchmark | Speculative Buy | 26 сент 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Yachin Guy | A | 19600 | 19600 | 23 дек 2022 г. |
| SIDRANSKY DAVID | A | 20450 | 20450 | 23 дек 2022 г. |
| Philips Mario | A | 13750 | 13750 | 23 дек 2022 г. |
| Adler Yaron | A | 15000 | 15000 | 23 дек 2022 г. |
| Nanda Ashish | A | 15850 | 15850 | 23 дек 2022 г. |
| Reithinger Neil | A | 15000 | 15000 | 14 июн 2022 г. |
| Caplan Vered | A | 85000 | 85000 | 14 июн 2022 г. |
| Assa Kunik Efrat | A | 15000 | 15000 | 14 июн 2022 г. |
| Caplan Vered | D | 0 | 278191 | 28 янв 2022 г. |
| Caplan Vered | A | 278191 | 278191 | 28 янв 2022 г. |
Новостная лента
Orgenesis Schedules Fourth Quarter 2022 Business Update Conference Call
GlobeNewsWire
17 мар 2023 г. в 09:00
GERMANTOWN, Md., March 17, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will host a conference call at 11:00 AM Eastern Time on Tuesday, March 21, 2023, to discuss the company's corporate progress and other developments.
New Dimensions Trading Discloses Large Position in ORGS / Orgenesis
24/7 Wall Street
23 ноя 2022 г. в 00:27
Fintel reports that New Dimensions Trading has filed a 13G form with the SEC disclosing ownership of 1,370,000 shares of Orgenesis Inc (ORGS).
Orgenesis (ORGS) Q3 2022 Earnings Call Transcript
Seeking Alpha
13 ноя 2022 г. в 21:29
Orgenesis (NASDAQ:ORGS ) Q3 2022 Earnings Conference Call November 11, 2022 8:00 AM ET Company Participants David Waldman - Investor Relations Vered Caplan - Chief Executive Officer Neil Reithinger - Chief Financial Officer Conference Call Participants Bruce Jackson - Benchmark Company Operator Good morning, ladies and gentlemen and welcome to the Orgenesis Third Quarter 2022 Business Update Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Mr.
Orgenesis Schedules Third Quarter 2022 Business Update Conference Call
GlobeNewsWire
10 ноя 2022 г. в 08:30
GERMANTOWN, Md., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, November 11, 2022 to discuss the company's corporate progress and other developments.
Orgenesis, Inc's (ORGS) CEO Vered Caplan on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
16 авг 2022 г. в 17:22
Orgenesis, Inc. (NASDAQ:ORGS ) Q2 2022 Earnings Conference Call August 16, 2022 11:00 AM ET Company Participants David Waldman – Investor Relations Vered Caplan – Chief Executive Officer Neil Reithinger – Chief Financial Officer Conference Call Participants Bruce Jackson – The Benchmark Company Operator Good day, ladies and gentlemen, and welcome to the Orgenesis Business Update Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, David Waldman from Investor Relations.